Granules India has informed that it enclosed the press release on December 30,2021 titled ‘Granules Pharmaceuticals, Inc. Receives ANDA Approval for Amphetamine Mixed Salts (IR Tablets)’.
The above information is a part of company’s filings submitted to BSE.